intuniv 1 mg retardtabletten
takeda pharma ag - guanfacinum - retardtabletten - guanfacinum 1 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.03570261 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 23.59 mg, povidonum k 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, pro compresso. - adhd nei bambini e negli adolescenti (6-17 anni) - synthetika
intuniv 2 mg retardtabletten
takeda pharma ag - guanfacinum - retardtabletten - guanfacinum 2 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.071402 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 47.18 mg, povidonum k 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, pro compresso. - adhd nei bambini e negli adolescenti (6-17 anni) - synthetika
intuniv 3 mg retardtabletten
takeda pharma ag - guanfacinum - retardtabletten - guanfacinum 3 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.04073661 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 39.80 mg, povidonum k 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, e 132, e 172 (flavum), pro compresso. - adhd nei bambini e negli adolescenti (6-17 anni) - synthetika
intuniv 4 mg retardtabletten
takeda pharma ag - guanfacinum - retardtabletten - guanfacinum 4 mg ut guanfacini hydrochloridum 4.56 mg, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.054581 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 53.07 mg, povidonum k 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, e 132, e 172 (flavum), pro compresso. - adhd nei bambini e negli adolescenti (6-17 anni) - synthetika
intuniv
takeda pharmaceuticals international ag ireland branch - guanfacine cloridrato - disturbo da deficit di attenzione con iperattività - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv deve essere utilizzato come parte di un completo trattamento dell'adhd programma, in genere, compresi psicologico, educativo e sociale, misure di.
nebivololo e idroclorotiazide sandoz
sandoz s.p.a. - nebivolol and thiazides - nebivolol and thiazides
kloralata
sigillata limited - nebivolol and thiazides - nebivolol and thiazides
hlaupnef
sigillata limited - nebivolol and thiazides - nebivolol and thiazides
carvedilolo sandoz
sandoz s.p.a. - carvedilolo - carvedilolo
carvedilolo hexal
sandoz s.p.a. - carvedilolo - carvedilolo